Summary
Cannot assess the user’s multiple ibuprofen+sertraline claims because the provided FDA label excerpts only contain the boxed warning about cardiovascular and gastrointestinal risk of NSAIDs (ibuprofen), and do not include any information about sertraline/SSRIs, platelet function, or specific interaction guidance.
Category Scores
Accurate Statements
WARNING: RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS
Boxed Warning — states NSAIDs increase risk of serious cardiovascular thrombotic events (including MI and stroke, which can be fatal) and serious GI adverse events (bleeding, ulceration, perforation, which can be fatal).
Unsupported Statements
Taking ibuprofen while on sertraline is usually possible for most people.
Provided excerpts contain no sertraline/SSRI-specific or interaction-specific guidance; no label support for “usually possible for most people.”
Using ibuprofen with sertraline increases the risk of gastrointestinal bleeding compared with using ibuprofen alone.
No label excerpt provided addressing sertraline-associated risk or the effect of combining sertraline with ibuprofen.
Sertraline can affect platelet function.
No label excerpt provided discussing sertraline effects on platelet function.
Ibuprofen can irritate the stomach and increase bleeding risk.
Label excerpts provided discuss GI inflammation/bleeding risk but do not explicitly support the phrasing “irritate the stomach.” (Inflammation and serious GI events are supported; specific wording is not.)
Using ibuprofen and sertraline together makes the additive effect on bleeding risk more likely.
No label excerpt provided about sertraline + ibuprofen additive bleeding risk.
GI bleeding symptoms to watch for include vomiting blood or material that looks like coffee grounds.
The provided excerpts do not list specific symptom checklists for GI bleeding.
GI bleeding symptoms to watch for include black, tarry stools.
The provided excerpts do not list specific symptom checklists for GI bleeding.
GI bleeding symptoms to watch for include visible blood in stool.
The provided excerpts do not list specific symptom checklists for GI bleeding.
GI bleeding symptoms to watch for include unexplained dizziness, weakness, or fainting.
The provided excerpts do not list specific symptom checklists for GI bleeding.
Extra caution is warranted when using ibuprofen with sertraline if there is a history of stomach ulcers or GI bleeding.
No sertraline-specific caution guidance is provided in the excerpts.
Extra caution is warranted when using ibuprofen with sertraline in older age.
The excerpts state elderly patients are at greater risk for serious GI events, but they do not provide sertraline-combination-specific caution language.
Extra caution is warranted when using ibuprofen with sertraline if other medicines that increase bleeding risk are used, including other antidepressants that affect serotonin.
No excerpt provided addressing serotonin antidepressants with ibuprofen.
Extra caution is warranted when using ibuprofen with sertraline if other medicines that increase bleeding risk are used, including anticoagulants such as warfarin or apixaban.
No excerpt provided listing anticoagulants (warfarin/apixaban) in the context of ibuprofen+sertraline or bleeding risk.
Extra caution is warranted when using ibuprofen with sertraline if other medicines that increase bleeding risk are used, including antiplatelet drugs such as aspirin or clopidogrel.
The provided excerpt supports that concurrent aspirin and an NSAID increases GI events, but does not support this “including… clopidogrel” statement or any sertraline-combination framing.
Extra caution is warranted when using ibuprofen with sertraline with high-dose or frequent NSAID use.
The excerpt supports higher doses are associated with increased CV thrombotic risk, but it does not provide sertraline-combination-specific caution or high-dose/frequency NSAID use phrased this way.
Using the lowest effective dose for the shortest time can lower risk when taking ibuprofen.
The excerpt supports this risk-minimization approach for CV thrombotic risk; it is not explicitly tied to GI risk in provided excerpts.
Avoid taking ibuprofen on an empty stomach to lower risk.
No provided excerpts address taking ibuprofen with food or empty stomach guidance.
Do not combine ibuprofen with other NSAIDs such as naproxen.
No provided excerpts address combining NSAIDs (e.g., ibuprofen with naproxen).
A stomach-protecting strategy such as a proton-pump inhibitor may be appropriate for people with risk factors.
No provided excerpts mention proton-pump inhibitors or stomach-protective strategies.
For pain or fever control in people taking SSRIs, acetaminophen (paracetamol) is often considered a lower bleeding-risk option than NSAIDs.
No provided excerpts address acetaminophen vs NSAID bleeding risk or SSRIs.
Contradictions
Important Omissions
Any label-supported statements about sertraline/SSRIs, platelet effects, or specific ibuprofen-sertraline interaction/monitoring guidance.
Importance:
High
Safety Assessment
Potential Patient Risk:
High
Multiple claims rely on sertraline-specific interaction and bleeding-risk details, but the provided label excerpts do not support those claims. This creates potential for misinformation about interaction risk and specific mitigation strategies/symptom watchfulness.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Most ibuprofen+sertraline and symptom/mitigation statements are not supported by the provided CALDOLOR label excerpts.
Suggested Improvement
Limit statements to the provided boxed warning and its directly quoted/covered GI and CV risk content; remove or re-source any sertraline/SSRI-specific interaction, platelet function, medication class examples (warfarin/apixaban/clopidogrel), symptom checklists, and specific mitigation guidance (PPI, avoid empty stomach, acetaminophen alternative) unless supported by additional label text.